<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00950079</url>
  </required_header>
  <id_info>
    <org_study_id>2007-0180</org_study_id>
    <nct_id>NCT00950079</nct_id>
  </id_info>
  <brief_title>Prevention of Contrast-Induced Nephropathy in Diabetic Patients With Undergoing Coronary Angiography</brief_title>
  <official_title>Preventive Strategies of REnal Insufficiency in Patients With Diabetes Undergoing InterVENTion or Arteriography(PREVENT Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CardioVascular Research Foundation, Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CardioVascular Research Foundation, Korea</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine whether sodium bicarbonate is superior to sodium
      chloride in preventing contrast induced nephropathy in diabetic patients undergoing coronary
      angiography or intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Contrast induced nephropathy (CIN) is a common cause of renal failure associated with
      prolonged hospitalization, significant morbidity or mortality, and cost. CIN has been
      reported to account for 10% of hospital acquired renal failure. Several strategies or
      medications were tried to prevent CIN. Of these, mucomyst and normal saline infusion are
      effective to prevent CIN. Sodium bicarbonate has shown mixed results from recent randomized
      trials. Moreover,limited data have been available for preventing CIN in diabetic renal
      dysfunction undergoing coronary angiography or intervention. Our hypothesis is that addition
      of sodium bicarbonate will be more efficacious than normal saline in preventing CIN at above
      situation.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2008</start_date>
  <completion_date type="Anticipated">January 2010</completion_date>
  <primary_completion_date type="Anticipated">August 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of contrast-induced nephropathy</measure>
    <time_frame>24 and 48 hours after angiography or intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>all-cause mortality</measure>
    <time_frame>30 days after index angiography</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stroke</measure>
    <time_frame>30 days after index angiography</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dialysis</measure>
    <time_frame>30 days after index angiography</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>30 days after index angiography</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>all-cause mortality</measure>
    <time_frame>30 days to 6 months after index angiography</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stroke</measure>
    <time_frame>30 days to 6 months after index angiography</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>dialysis</measure>
    <time_frame>30 days to 6 months after index angiography</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>myocardial infarction</measure>
    <time_frame>30 days to 6 months after index angiography</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">368</enrollment>
  <condition>Contrast Induced Nephropathy</condition>
  <arm_group>
    <arm_group_label>Sodium bicarbonate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>sodium bicarbonate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>saline infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium bicarbonate</intervention_name>
    <description>3 mL/kg for 1 hour immediately before contrast injection , 1mg/kg/hr during procedure and 6 hours after procedure</description>
    <arm_group_label>Sodium bicarbonate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline</intervention_name>
    <description>0.9% normal saline with 1 mL/kg/hr infusion 12 hours before procedure and 12 hours after procedure</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age&gt;18 years, no upper limits

          -  diabetes treated with insulin or oral hypoglycemic agents

          -  serum creatinine &gt;=1.1 and

          -  resting estimated glomerular filtration rate &lt;60ml/min/1.73 square meter

        Exclusion Criteria:

          -  serum creatinine &gt;=8mg/dL

          -  resting estimated GFR &lt;15ml/min/1.73 square meter

          -  end stage renal disease on hemodialysis

          -  multiple myeloma

          -  uncontrolled hypertension (systolic BP &gt;160mmHg or diastolic BP&gt;100mmHg)

          -  acute myocardial infarction

          -  emergent coronary angioplasty or angiography

          -  recent use of contrast within 2 days

          -  allergic reaction to contrast

          -  pregnancy

          -  allergic to following medication : theophylline, dopamine, mannitol, fenoldopam,
             N-acetylcysteine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seong-Wook Park, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seong-Wook Park, MD, PhD</last_name>
    <phone>2-3010-3153</phone>
    <phone_ext>82</phone_ext>
    <email>swpark@amc.seoul.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Seung-Whan Lee, MD, PhD</last_name>
    <phone>2-3010-3170</phone>
    <phone_ext>82</phone_ext>
    <email>seungwlee@amc.seoul.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Soonchunhyang University Bucheon Hospital</name>
      <address>
        <city>Bucheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nae-Hee Lee, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Nae-Hee Lee, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Busan Saint Mary Hospital</name>
      <address>
        <city>Busan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jae-Sik Jang, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jae-Sik Jang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Soonchunhyang University Hospital, Cheonan</name>
      <address>
        <city>Cheonan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Won-Yong Shin, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Dong-Gyu Jin, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kangwon National University Hospital</name>
      <address>
        <city>Chuncheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bong-Ki Lee, MD, PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Bong-Ki Lee</last_name>
    </contact_backup>
    <investigator>
      <last_name>Bong-Ki Lee, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chungnam National University Hospital</name>
      <address>
        <city>Daejeon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>In-Whan Seong, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>In-Whan Seong, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gangneung Asan Hospital</name>
      <address>
        <city>Gangneung</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sang-Sik Cheong</last_name>
    </contact>
    <investigator>
      <last_name>Sang-Sik Cheong, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>138-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seong-Wook Park, MD, PhD</last_name>
      <phone>2-3010-3153</phone>
      <phone_ext>82</phone_ext>
      <email>swpark@amc.seoul.kr</email>
    </contact>
    <contact_backup>
      <last_name>Seung-Whan Lee, MD, PhD</last_name>
      <phone>2-3010-3170</phone>
      <phone_ext>82</phone_ext>
      <email>seungwlee@amc.seoul.kr</email>
    </contact_backup>
    <investigator>
      <last_name>Seong-Wook Park, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Soonchunhyang University Seoul Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Min-Su Hyun, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Min-Su Hyun, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ulsan University Hospital</name>
      <address>
        <city>Ulsan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sang-Gon Lee, MD, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Sang-Gon Lee, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2009</study_first_submitted>
  <study_first_submitted_qc>July 30, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 31, 2009</study_first_posted>
  <last_update_submitted>July 30, 2009</last_update_submitted>
  <last_update_submitted_qc>July 30, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 31, 2009</last_update_posted>
  <responsible_party>
    <name_title>Seong-Wook Park, MD, PhD</name_title>
    <organization>Asan Medical Center</organization>
  </responsible_party>
  <keyword>sodium bicarbonate</keyword>
  <keyword>diabetes mellitus</keyword>
  <keyword>coronary angiography or intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

